Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinoma.

Autor: Ghandour RA; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX; Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH. Electronic address: vitaly.margulis@utsouthwestern.edu., Freifeld Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX., Cheaib J; The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD., Singla N; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX; The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD., Meng X; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX., Kenigsberg A; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX., Bagrodia A; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX., Woldu S; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX., Hoffman-Censits J; The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD., Enikeev D; Institute for Urology and Reproductive Health, Sechenov University, Moscow., Rapoport L; Institute for Urology and Reproductive Health, Sechenov University, Moscow., Petros FG; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX., Raman JD; Division of Urology, Penn State Health Milton S. Hershey Medical Center, Hershey, PA., Pierorazio PM; The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD., Matin SF; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX., Margulis V; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX; Institute for Urology and Reproductive Health, Sechenov University, Moscow.

Publikováno v: Urologic oncology [Urol Oncol] 2021 Nov; Vol. 39 (11), pp. 788.e15-788.e21. Date of Electronic Publication: 2021 Jul 28.

Oxidative stress in Strongylus spp. infected donkeys treated with piperazine citrate versus doramectin.

Autor: Elmeligy E; Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Assiut University, Assiut, Egypt., Abdelbaset A; Division of Clinical Laboratory Diagnosis, Department of Animal Medicine, Faculty of Veterinary Medicine, Assiut University, Assiut, Egypt., Elsayed HK; Division of Internal Medicine, Department of Animal Medicine, Faculty of Veterinary Medicine, Assiut University, Assiut, Egypt., Bayomi SA; Division of Clinical Laboratory Diagnosis, Department of Animal Medicine, Faculty of Veterinary Medicine, Assiut University, Assiut, Egypt., Hafez A; Department of Pharmacology, Faculty of Veterinary Medicine, Aswan University, Aswan, Egypt., Abu-Seida AM; Department of Surgery, Anesthesiology and Radiology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt., El-Khabaz KAS; Division of Infectious Diseases, Department of Animal Medicine, Faculty of Veterinary Medicine, Assiut University, Assiut, Egypt., Hassan D; Department of Animal & Poultry Hygiene and Environmental Sanitation, Faculty of Veterinary Medicine, Assiut University, Assiut, Egypt., Ghandour RA; Department of physiology, Faculty of Veterinary Medicine, Cairo University, P.O. Box 12211, Giza, Egypt., Khalphallah A; Division of Internal Medicine, Department of Animal Medicine, Faculty of Veterinary Medicine, Assiut University, Assiut, Egypt.

Publikováno v: Open veterinary journal [Open Vet J] 2021 Apr-Jun; Vol. 11 (2), pp. 238-250. Date of Electronic Publication: 2021 May 06.

Pathologic stage as a surrogate for oncologic outcomes after receipt of neoadjuvant chemotherapy for high-grade upper tract urothelial carcinoma.

Autor: Singla N; Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX., Christie A; Division of Biostatistics, Department of Clinical Sciences, The University of Texas Southwestern Medical Center, Dallas, TX., Freifeld Y; Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX., Ghandour RA; Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX., Woldu SL; Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX., Clinton TN; Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX., Petros FG; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX., Robyak H; Division of Urology, Department of Surgery, Penn State Health Milton S. Hershey Medical Center, Hershey, PA., Yeh HC; Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX; Department of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan., Fang D; Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China., Enikeev D; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia., Bagrodia A; Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX., Sagalowsky AI; Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX., Lotan Y; Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX., Raman JD; Division of Urology, Department of Surgery, Penn State Health Milton S. Hershey Medical Center, Hershey, PA., Matin SF; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX., Margulis V; Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia. Electronic address: vitaly.margulis@utsouthwestern.edu.

Publikováno v: Urologic oncology [Urol Oncol] 2020 Dec; Vol. 38 (12), pp. 933.e7-933.e12. Date of Electronic Publication: 2020 May 16.

Overcoming sociodemographic factors in the care of patients with testicular cancer at a safety net hospital.

Autor: Chertack N; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Ghandour RA; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Singla N; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Freifeld Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Hutchinson RC; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Courtney K; Division of Hematology and Oncology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas., Bowman IA; Division of Hematology and Oncology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas., Arafat W; Division of Hematology and Oncology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas., Meng X; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Moore JA; Division of Hematology and Oncology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas., Aydin AM; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Sagalowsky AI; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Margulis V; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Lotan Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Woldu SL; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Bagrodia A; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas.

Publikováno v: Cancer [Cancer] 2020 Oct 01; Vol. 126 (19), pp. 4362-4370. Date of Electronic Publication: 2020 Aug 10.

Improved survival after cytoreductive nephrectomy for metastatic renal cell carcinoma in the contemporary immunotherapy era: An analysis of the National Cancer Database.

Autor: Singla N; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Hutchinson RC; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX., Ghandour RA; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX., Freifeld Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX., Fang D; Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China., Sagalowsky AI; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX., Lotan Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX., Bagrodia A; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX., Margulis V; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX; Department of Urology, I.M. Sechenov First Moscow State University, Moscow, Russia., Hammers HJ; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Woldu SL; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address: solomon.woldu@utsouthwestern.edu.

Publikováno v: Urologic oncology [Urol Oncol] 2020 Jun; Vol. 38 (6), pp. 604.e9-604.e17. Date of Electronic Publication: 2020 Apr 03.